These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36434071)

  • 21. Interleukin-17A derived from mast cells contributes to fibrosis in gastric cancer with peritoneal dissemination.
    Gunjigake K; Kinoshita J; Yamaguchi T; Saito H; Fujimori D; Horiike T; Harada S; Tajima H; Ninomiya I; Ohta T; Fushida S
    Gastric Cancer; 2021 Jan; 24(1):31-44. PubMed ID: 32488650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candidate host marker for peritoneal dissemination.
    Hashizume K; Uchiyama A; Sasaki N; Noshiro H; Morisaki T; Tanaka M; Katano M
    Anticancer Res; 2002; 22(3):1781-6. PubMed ID: 12168869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new peritoneal dissemination model established from the human pancreatic cancer cell line.
    Nishimori H; Yasoshima T; Denno R; Shishido T; Hata F; Honma T; Ura H; Yamaguchi K; Yagihashi A; Tanaka H; Kawaguchi S; Kamiguchi K; Isomura H; Sato N; Hirata K
    Pancreas; 2001 May; 22(4):348-56. PubMed ID: 11345134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and characterization of a high metastatic potential in the peritoneum for human gastric cancer by orthotopic tumor cell implantation.
    Bai F; Guo X; Yang L; Wang J; Shi Y; Zhang F; Zhai H; Lu Y; Xie H; Wu K; Fan D
    Dig Dis Sci; 2007 Jun; 52(6):1571-8. PubMed ID: 17404872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs Associated with Epithelial-Mesenchymal Transition Can Be Targeted to Inhibit Peritoneal Dissemination of Human Scirrhous Gastric Cancers.
    Takei Y; Shen G; Morita-Kondo A; Hara T; Mihara K; Yanagihara K
    Pathobiology; 2018; 85(4):232-246. PubMed ID: 29847827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrin alpha6beta4 as a suppressor and a predictive marker for peritoneal dissemination in human gastric cancer.
    Ishii Y; Ochiai A; Yamada T; Akimoto S; Yanagihara K; Kitajima M; Hirohashi S
    Gastroenterology; 2000 Mar; 118(3):497-506. PubMed ID: 10702200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tumor cell dissemination in bone marrow and peritoneal cavity. An immunocytochemical study of patients with stomach or colorectal carcinoma].
    Broll R; Lembcke K; Stock C; Zingler M; Duchrow M; Schimmelpenning H; Strik M; Muller G; Kujath P; Bruch HP
    Langenbecks Arch Chir; 1996; 381(1):51-8. PubMed ID: 8717176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long Noncoding RNA HOTAIR Promotes Epithelial-Mesenchymal Transition and Is a Suitable Target to Inhibit Peritoneal Dissemination in Human Scirrhous Gastric Cancers.
    Takei Y; Hara T; Suzuki A; Mihara K; Yanagihara K
    Pathobiology; 2020; 87(5):277-290. PubMed ID: 32937635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanism by which peritoneal disseminated metastasis develops in gastric cancer].
    Imada T; Matsumoto A
    Nihon Geka Gakkai Zasshi; 1986 Jun; 87(6):593-603. PubMed ID: 3736535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of peritoneal dissemination of colon cancer by hyperthermic CO2 insufflation: A novel approach to prevent intraperitoneal tumor spread.
    Peng Y; Yang H; Ye Q; Zhou H; Zheng M; Shi Y
    PLoS One; 2017; 12(2):e0172097. PubMed ID: 28207849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer.
    Sako A; Kitayama J; Koyama H; Ueno H; Uchida H; Hamada H; Nagawa H
    Cancer Res; 2004 May; 64(10):3624-8. PubMed ID: 15150121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancer.
    Oshima T; Yamada R; Hatori S; Kunisaki C; Imada T
    Oncol Rep; 2006 Aug; 16(2):361-6. PubMed ID: 16820916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new surgical approach (peritonectomy) for the treatment of peritoneal dissemination.
    Yonemura Y; Fujimura T; Fushida S; Fujita H; Bando E; Nishimura G; Miwa K; Endou Y; Tanaka M; Sasaki T
    Hepatogastroenterology; 1999; 46(25):601-9. PubMed ID: 10228868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide.
    Yonemura Y; Endo Y; Fujita H; Kimura K; Sugiyama K; Momiyama N; Shimada H; Sasaki T
    J Exp Clin Cancer Res; 2001 Jun; 20(2):205-12. PubMed ID: 11484976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Significance of Peritoneal Metastasis in Stage IV Colorectal Cancer Patients With R0 Resection: A Multicenter, Retrospective Study.
    Arakawa K; Kawai K; Ishihara S; Hata K; Nozawa H; Oba K; Sugihara K; Watanabe T
    Dis Colon Rectum; 2017 Oct; 60(10):1041-1049. PubMed ID: 28891847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lentivirus-mediated RNA silencing of c-Met markedly suppresses peritoneal dissemination of gastric cancer in vitro and in vivo.
    Wang XL; Chen XM; Fang JP; Yang CQ
    Acta Pharmacol Sin; 2012 Apr; 33(4):513-22. PubMed ID: 22407230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition.
    Li Q; Li B; Li Q; Wei S; He Z; Huang X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
    Cell Death Dis; 2018 Aug; 9(9):854. PubMed ID: 30154401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway.
    Wang X; Che X; Yu Y; Cheng Y; Bai M; Yang Z; Guo Q; Xie X; Li D; Guo M; Hou K; Guo W; Qu X; Cao L
    J Exp Clin Cancer Res; 2020 Oct; 39(1):221. PubMed ID: 33081836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Removal of small extracellular vesicles inhibits the progression of peritoneal dissemination in gastric cancer.
    Shibamoto J; Arita T; Konishi H; Kataoka S; Furuke H; Takaki W; Takabatake K; Kiuchi J; Ohashi T; Shimizu H; Yamamoto Y; Komatsu S; Shiozaki A; Kubota T; Okamoto K; Otsuji E
    Gastric Cancer; 2022 Jul; 25(4):712-725. PubMed ID: 35368210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination.
    Emoto S; Ishigami H; Yamashita H; Yamaguchi H; Kaisaki S; Kitayama J
    Gastric Cancer; 2012 Apr; 15(2):154-61. PubMed ID: 21892754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.